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Objectives: Commercially available Aortouniiliac (AUI)
devices are most often described as rescue therapy for compli-
cations of endovascular aneurysm repair. They have also been
described to be useful in several settings including ruptured
AAA and difficult aortoiliac anatomy. We report on the
indications and outcomes with AUI devices in a single
center.
Methods: We retrospectively identified all patients
who underwent AUI repair in a single center during a
five-year period. Patients were evaluated for indications
of AUI placement, complications of surgery, and overall
mortality. Patient demographics, indications for proce-
dure, perioperative outcomes and mortality data were
analyzed.
Results: There were 38 patients identified having un-
dergone AUI with femoral-femoral bypass with a mean age
of 75.68.9 years. Cook converters including the Renu
were used in 97% of the cases. The indications were elective
aneurysm repair with anatomic constraints (47%), compli-
cations of previous EVAR (29%), rupture (13%) and aor-
toiliac occlusive disease (11%). Of those patients who un-
derwent elective aneurysm repair 35% had concomitant iliac
aneurysms and 29% had occlusive disease in the aortoiliac
system. Non-aneurysm related mortality was 26% within
the five year period. Of the patients alive, the mean overall
follow-up is 28 (9-62) months. There were no aneurysm
related deaths identified. There was an 18% complication
rate. Of those complications identified, 1 was a major
endoleak requiring secondary intervention. The remaining
complications included femoral wound infections (n3),
femoral-femoral bypass occlusion (n2) and pulmonary
complications (n1).
Conclusions: AUI devices are an effective treatment
for aortoiliac aneurysms with challenging anatomy, rup-
ture, or as rescue endoluminal therapy. They may also
have a role in patients with aortoiliac occlusive disease.
Further research is needed to delineate this patient
subset.
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Objectives: The high proportion of patients with pop-
liteal arterial aneurysms (PAA) that suffer from abdominal
aortic aneurysms (AAA) 9-64% is wellknown, and a high
proportion of AAA patients also suffer from TAA
(25%).The proportion of persons with concurrent PAA;
AAA and TAA has not been investigated previously. One
major obstacle in the analysis is the poorly established
definitions for PAA and TAA. The primary aim was to
analyse the prevalence of concurrent aneurysms; PAA, TAA
or AAA in a cohort of patients treated for PAA.
Methods: Charts for all persons treated for acute and
elective repair for infrainguinal disease (operation/throm-
bolysis) at the Karolinska University Hospital 2004-2010
were investigated, persons treated for PAA were included
(n70). Diagnosis; AAA: AP maximum diameter 3 cm,
TAA; according to radiological diagnosis. Only treated
PAA are included.
Results: 3/70 were women. Mean age was 71 years
among 29 persons treated for unilateral PAA (41%) vs 73
years in 41 persons treated for bilateral PAA (59%) p0.08.
39/70 had AAA (56%). More patients with bilateral
than unilateral PAA had AAA (68% vs 37%, p0.01). 9/70
had TAA (13%), all with concurrent AAA. 7 (10%) have
TAA, AAA and bilateral PAA, mean age; 79 years, vs 71
years, p0.005.
Conclusions:More than 10% of persons with PAA also
have TAA and AAA, high age increases the risk for concur-
rent aneurysms. An underestimation of the diagnosis TAA
and PAA is highly plausible, and higher prevalence rates of
multilevel aneurysm disease can be expected if special at-
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